Cancer Screening Trial Shows Survival Rate Increases When Disease Caught Early
By MedImaging International staff writers Posted on 13 Jun 2016 |
Image: The UK Lung cancer Screening trial found screening high-risk individuals can identify those individuals with early stage disease, and significantly increase their chance of long-term survival (Photo courtesy of Queen Mary University of London).
The first ever UK Lung cancer Screening trial (UKLS) has shown that identifying early stage cancer in patients with a high risk of developing the disease can increase their chance of survival for five years or longer, by 73%.
The aim of the study was to highlight the need for a screening program for high-risk groups. Part of the reason lung cancer outcomes in the UK are poor, is because around 70% of patients first present to specialist care when it is already too late for effective treatment.
The study was led by researchers from the University of Liverpool (Liverpool, UK), Liverpool Heart & Chest Hospital, Royal Brompton & Harefield Hospital, and Papworth Hospital. The researchers screened patients using a technology called Low Dose Computed Tomography (LDCT) for the randomized controlled trial.
The results of the new trial showed that the clinical outcome is greatly improved for high-risk patients identified with early stage disease. Such patients have up to a 73% better chance of survival for five years or longer. More than 80% of such patients had surgery to treat the cancer.
Dr Edward Gaynor, Clinical lead on cancer for Liverpool Clinical Commissioning Group, said: "The UKLS study is a further piece of evidence that low dose CT in high risk individuals can save lives. This is particularly relevant in Liverpool where we have one of the highest incidences and mortality rates of lung cancer and the Liverpool Clinical Commissioning Group is actively exploring how it can apply the findings in this study to the benefit of Liverpool through the Healthy Lung Project."
Related Links:
University of Liverpool
The aim of the study was to highlight the need for a screening program for high-risk groups. Part of the reason lung cancer outcomes in the UK are poor, is because around 70% of patients first present to specialist care when it is already too late for effective treatment.
The study was led by researchers from the University of Liverpool (Liverpool, UK), Liverpool Heart & Chest Hospital, Royal Brompton & Harefield Hospital, and Papworth Hospital. The researchers screened patients using a technology called Low Dose Computed Tomography (LDCT) for the randomized controlled trial.
The results of the new trial showed that the clinical outcome is greatly improved for high-risk patients identified with early stage disease. Such patients have up to a 73% better chance of survival for five years or longer. More than 80% of such patients had surgery to treat the cancer.
Dr Edward Gaynor, Clinical lead on cancer for Liverpool Clinical Commissioning Group, said: "The UKLS study is a further piece of evidence that low dose CT in high risk individuals can save lives. This is particularly relevant in Liverpool where we have one of the highest incidences and mortality rates of lung cancer and the Liverpool Clinical Commissioning Group is actively exploring how it can apply the findings in this study to the benefit of Liverpool through the Healthy Lung Project."
Related Links:
University of Liverpool
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection